BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 241 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,116,855 | +1.4% | 1,852,663 | +0.8% | 0.00% | +50.0% |
| Q2 2023 | $12,936,149 | -12.0% | 1,837,521 | +4.2% | 0.00% | -33.3% |
| Q1 2023 | $14,704,246 | -26.7% | 1,763,099 | +0.9% | 0.00% | -25.0% |
| Q4 2022 | $20,060,840 | -11.4% | 1,747,460 | -2.7% | 0.00% | -20.0% |
| Q3 2022 | $22,639,000 | +17.8% | 1,796,791 | -1.1% | 0.01% | +25.0% |
| Q2 2022 | $19,223,000 | -34.3% | 1,816,884 | +0.9% | 0.00% | -20.0% |
| Q1 2022 | $29,266,000 | +13.5% | 1,799,898 | -3.3% | 0.01% | +25.0% |
| Q4 2021 | $25,775,000 | -26.4% | 1,861,008 | -23.7% | 0.00% | -33.3% |
| Q3 2021 | $35,028,000 | -9.9% | 2,437,584 | -0.9% | 0.01% | -14.3% |
| Q2 2021 | $38,897,000 | +95.9% | 2,460,312 | +26.0% | 0.01% | +75.0% |
| Q1 2021 | $19,853,000 | +29.2% | 1,952,128 | -5.4% | 0.00% | +33.3% |
| Q4 2020 | $15,371,000 | +114.1% | 2,063,107 | -1.3% | 0.00% | +50.0% |
| Q3 2020 | $7,181,000 | -21.8% | 2,090,426 | +8.4% | 0.00% | 0.0% |
| Q2 2020 | $9,187,000 | +145.8% | 1,928,226 | +3.2% | 0.00% | +100.0% |
| Q1 2020 | $3,738,000 | -40.8% | 1,869,130 | +2.1% | 0.00% | 0.0% |
| Q4 2019 | $6,315,000 | +61.1% | 1,830,432 | +33.8% | 0.00% | 0.0% |
| Q3 2019 | $3,919,000 | -24.1% | 1,367,802 | +0.3% | 0.00% | 0.0% |
| Q2 2019 | $5,165,000 | -53.4% | 1,363,049 | +0.2% | 0.00% | -66.7% |
| Q1 2019 | $11,078,000 | +1.6% | 1,360,934 | +0.8% | 0.00% | 0.0% |
| Q4 2018 | $10,899,000 | +5.5% | 1,350,616 | -0.2% | 0.00% | 0.0% |
| Q3 2018 | $10,330,000 | +48.4% | 1,353,833 | +11.5% | 0.00% | +50.0% |
| Q2 2018 | $6,960,000 | +22.7% | 1,214,561 | +2.2% | 0.00% | +100.0% |
| Q1 2018 | $5,671,000 | -1.8% | 1,188,876 | +1.1% | 0.00% | 0.0% |
| Q4 2017 | $5,773,000 | +9.0% | 1,175,832 | +16.3% | 0.00% | 0.0% |
| Q3 2017 | $5,297,000 | -5.4% | 1,010,875 | +0.4% | 0.00% | -50.0% |
| Q2 2017 | $5,599,000 | -26.6% | 1,006,840 | +10.8% | 0.00% | 0.0% |
| Q1 2017 | $7,633,000 | +38.2% | 908,763 | +4.2% | 0.00% | 0.0% |
| Q4 2016 | $5,523,000 | +46.3% | 872,520 | +1.9% | 0.00% | +100.0% |
| Q3 2016 | $3,775,000 | +53.8% | 855,991 | -0.9% | 0.00% | 0.0% |
| Q2 2016 | $2,454,000 | +1.7% | 863,925 | +3.8% | 0.00% | 0.0% |
| Q1 2016 | $2,412,000 | -74.1% | 832,663 | -7.9% | 0.00% | -66.7% |
| Q4 2015 | $9,327,000 | -9.0% | 903,786 | +0.5% | 0.00% | 0.0% |
| Q3 2015 | $10,251,000 | -9.8% | 899,132 | +18.1% | 0.00% | 0.0% |
| Q2 2015 | $11,363,000 | +51.8% | 761,045 | -8.2% | 0.00% | +50.0% |
| Q1 2015 | $7,486,000 | -26.6% | 828,938 | -1.2% | 0.00% | -33.3% |
| Q4 2014 | $10,202,000 | +24.0% | 839,066 | -0.3% | 0.00% | 0.0% |
| Q3 2014 | $8,228,000 | +171.0% | 841,227 | +253.3% | 0.00% | +200.0% |
| Q2 2014 | $3,036,000 | +149.9% | 238,090 | +107.2% | 0.00% | – |
| Q1 2014 | $1,215,000 | +39.0% | 114,904 | -0.1% | 0.00% | – |
| Q4 2013 | $874,000 | +16.1% | 114,991 | +11.1% | 0.00% | – |
| Q3 2013 | $753,000 | -1.8% | 103,511 | -79.1% | 0.00% | – |
| Q2 2013 | $767,000 | – | 495,047 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Burrage Capital Management LLC | 1,105,673 | $8,237,000 | 6.28% |
| Sarissa Capital Management LP | 8,175,000 | $60,903,000 | 6.22% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,980,870 | $22,207,000 | 2.78% |
| DG Capital Management, LLC | 1,075,732 | $8,014,000 | 1.70% |
| Ghost Tree Capital, LLC | 900,000 | $6,705,000 | 1.49% |
| Parkman Healthcare Partners LLC | 538,370 | $4,011,000 | 1.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 5,835,810 | $43,477,000 | 0.86% |
| Formidable Asset Management, LLC | 470,419 | $3,470,000 | 0.80% |
| KNOTT DAVID M | 219,461 | $1,635,000 | 0.74% |
| Altium Capital Management LP | 250,000 | $1,863,000 | 0.70% |